Table of Contents Table of Contents
Previous Page  28 / 39 Next Page
Information
Show Menu
Previous Page 28 / 39 Next Page
Page Background

Date

Day 1 - 24

th

November 2015 (Tuesday)

Session

Session 3: ‘Perspective of the Technology Investors’

Time

17:05-18:05

Format

Panel Discussion (Panelist)

Topic

Perspective of the Technology Investors

Speaker

Mr. Benny Pang

Managing Partner of Loeb & Loeb Hong Kong

Benny Pang practices corporate finance and securities law in Hong Kong, focusing on

equity capital markets and mergers and acquisitions. Mr. Pang has worked on a broad

range of corporate transactions with private and public companies. In addition, he has

substantial experience representing issuers and underwriters in equity fundraising

transactions, including share placements, rights issues and open offers, and he has

completed over 80 and participated in more than 100 Hong Kong initial public offerings,

including global offering of H-shares of SOEs. He has represented clients in Europe,

Russia, Central Asia, North Asia and South East Asia, the Middle East, the United

States, Canada, South Africa, India and Australia.

Mr. Pang has over 18 years of experience in the legal industry in Australia and in Hong

Kong. Mr. Pang is currently the managing partner of Messrs. Pang & Co., in association

with Loeb & Loeb LLP. Mr. Pang graduated with a Bachelor of Laws degree from the

Bond University, Australia, in

1996 and with a Master of Laws degree from the University of New South Wales,

Australia, in 1997. Mr. Pang has been admitted as a legal practitioner of the Supreme

Court of New South Wales, Australia since 1997. Mr. Pang was admitted as a solicitor

of the High Court of Hong Kong since 2009. Mr. Pang is a member of both the Law

Society of New South Wales and the Law Society of Hong Kong.

Mr. Pang has been appointed as an independent non-executive director of Yuanda

China Holdings Limited (Stock Code: 2789), a company listed on the Main Board of the

Stock Exchange,

since 2011. Mr. Pang has also been appointed as an independent non-executive

director of China Bio-Med Regeneration Technology Limited (GEM Stock Code: 8158)

and Goldenmars Technology Holdings Limited (GEM Stock Code: 8036), companies

listed on GEM, since 2012 and 2013, respectively.